GENE ONLINE|News &
Opinion
Blog

Psoriasis
Funding Psoriasis
Moonlake Announces $250 Million Public Offering
2023-06-29
Licensing China
Amgen Out-Licenses Two Therapies to Fosun Pharma to Expand Presence in China
2022-06-28
Trials & Approvals Tapinarof
Dermavant Sciences’ Psoriasis Drug Promises in Phase 3 Trials
2021-02-20
Trials & Approvals Tyrosine Kinase 2
Bristol Myers Squibb Registers Another Trial Win for its Psoriasis Med
2021-02-03
Trials & Approvals
Bristol Myers Squibb’s Deucravacitinib Impresses in Phase 3 Psoriasis Trial
2020-11-04
Trials & Approvals IL-17A
Cosentyx Bags EU Approval for First-Line Treatment of Pediatric Psoriasis
2020-08-05
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
READ MORE
EVENT
2023-10-04
BioFuture 2023
New York city,USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top